We Help Companies Find New Sales Opportunities
Chemicals & Pharmaceuticals - 2015
ICL is planning to extend its Boulby potash mining operation in Cleveland until 2060.
Produce Investments has acquired Andrew Farming, the Cornwall-based daffodil growing firm, for undisclosed terms.
Jotun Paints (Europe) is to set up a £4m 100,000 sq ft research and development facility at its paint plant in Flixborough.
AstraZeneca is to invest £75m in a new warehouse and packing facility at its site in Macclesfield, securing the future of 3,500 jobs.
Premaitha Health has secured a £5m investment in its Manchester-based prenatal screening test business from Thermo Fisher Scientific.
4d pharma is looking to raise £30m for the expansion of its Manchester-based biotherapeutics development business.
Statestrong Products, the Lytham-based toiletries supplier with about 50 staff, has been bought out of administration by Wachem of Croatia.
Alloga UK is to set up a 220,000 sq ft pharmaceuticals warehouse at Castlewood Business Park due to open in the East Midlands by the end of next year.
Alliance Pharma is to acquire the non-aesthetics business of London-based Sinclair IS Pharma for £132m.
Dr Organic is to set up a head office, manufacturing and distribution centre in Swansea for its cosmetics and food supplements business, with the creation of up to 110 jobs over the next three years.
Biopta has been acquired by Reprocell of Japan for £5.5m, and hopes to expand the 18-strong workforce at its Glasgow-based drug development business to 30 over the next three years.
Sanofi is seeking approval for the expansion and refurbishment of its pharmaceuticals site at Holmes Chapel in Cheshire by the end of next year.
Science Group is to invest £8m in the relocation of its science and technology advisory business to a 35,000 sq ft office and laboratory facility at Great Burgh in Epsom next year.
Almac is to invest £16m in a new pharmaceutical services facility at Charnwood Campus in Loughborough by 2017, with the creation of 180 jobs over the next five years.
Premiere Products is relocating the Gloucestershire-based sales and customer services division of its cleaning products business to a 2,250 sq ft office at Tewkesbury Business Park.
Alfacyte is to relocate its Glasgow-based pharmaceutical business to Lanarkshire's BioCity by December.
Biffa is to acquire the chemical treatment division of Enviroco, including its hazardous waste fleet and Sheffield-based waste transfer facility.
Illumina of the US is to relocate the European headquarters of its genomics research business to a new £60m 155,000 sq ft facility at Granta Park in Cambridge.
Bayer is to relocate its UK pharmaceuticals headquarters and about 470 staff from Newbury to Green Park in Reading.
MooGoo of Australia has acquired a 5,000 sq ft unit at Slough Trading Estate for its skincare products business.
Chemtest Ireland is to create 15 new jobs at its Belfast-based microbiology and asbestos-testing business.
Concept Life Sciences has acquired Agenda1 Analytical Services, the Bradford-based pharmaceutical testing firm with 30 staff.
Kosei Pharma has acquired a 13,000 sq ft warehouse at the Slough Trading Estate for the expansion of its pharmaceutical products distribution operation.
Sun European Partners is to acquire Finlays Horticulture Investments, the horticulture division of London-based James Finlay, for undisclosed terms.
Beauty Bay is to relocate its Manchester-based online beauty retail business to a 7,600 sq ft office at Exchange Quay in Salford.
Laleham Health & Beauty has acquired Design Plus, the Lancashire-based beauty contract manufacturing firm.
Biffa has acquired the chemical treatment business of PHS Group, including three hazardous waste facilities in Burscough, Stevenage and Atherstone.
UDG Healthcare is to sell Sangers, the Castlereagh-based pharmaceutical distribution firm with 200 staff, to McKesson of the US for £300m.
Ineos is to build a new £20m headquarters at its 1,700-acre petrochemical manufacturing site in Grangemouth by September 2016.
Shield Therapeutics is planning to more than double the 20-strong workforce at its Gateshead-based pharmaceuticals business over the next year.
Lumora, the Ely-based molecular products manufacturer, has been acquired by ERBA Diagnostics Mannheim of Germany for undisclosed terms.
Lab M Holdings, the Manchester-based microbiological testing firm, has been acquired by Neogen Corporation of the US for undisclosed terms.
Akzo Nobel is to expand its paint manufacturing operation on Tyneside with a new £1m test plant in 2016.
Oxitec, the Abingdon-based biological control firm, has been acquired by Intrexon of the US for £102m.
Gilead of the US is to expand its biotechnology operations in Cambridge with a new £28m 93,000 sq ft building at Granta Park by 2017.
Concept Life Sciences has acquired CXR Biosciences, the Dundee-based toxicology firm with 33 staff.
QuantuMDx is planning to triple its 50-strong workforce next year, following its relocation to a 20,000 sq ft office on the Quayside in Newcastle.
Accelovance of the US is to open a European headquarters for its biotechnology business in Swansea, with the creation of up to 70 jobs.
L'Oreal is reported to be looking to relocate its London-based cosmetics training academy to the 16,000 sq ft Lighthouse building at King's Cross.
New Era Aquaculture has been bought out of administration by a new company called World Feeds, securing 16 jobs at its South Yorkshire-based fish foods business.
Westland Horticulture has acquired William Sinclair out of administration, securing over 280 jobs at the Lincolnshire-based horticultural firm.
Syngenta of Switzerland is to open an agricultural research operations centre at Didsbury in Manchester in August, with the creation of 140 jobs.
Source BioScience is to acquire Select Pharma Laboratories, the Stirling-based pharmaceutical testing firm, for up to £7.3m.
Horizon Discovery is to invest £10m in its Cambridge-based molecular cancer therapeutics research business over the next two years.
ParkAcre Enterprises is looking to expand its vitamins production plant at Hemswell Cliff in Lincolnshire, with the creation of 60 jobs.
Baxalta is to house up to 100 staff at its new biotechnology research headquarters in Staines.
Charlotte Tilbury is to relocate its London-based cosmetics business to a 5,300 sq ft office at 50 Brook Green in Hammersmith.
Manchester Science Parks has secured government funding for a £5m medical research centre at Alderley Park in Cheshire.
MAC Clinical Research is setting up a 16,000 sq ft medical research centre at Citylabs in Manchester.
Quantum Pharma has acquired NuPharm Group, the Deeside-based pharmaceuticals supplier, for £9.3m.
Alent, the Woking-based supplier of chemicals for electronics, is to be acquired by US-based Platform Specialty Products for £1bn.
Randox is to create a further 15 jobs at its new biosciences research division in Co Antrim by the end of the year.
Boots has acquired Liz Earle, the Isle of Wight-based skincare firm with 600 staff, from Avon for £140m.
Westland Horticulture is creating 70 new jobs in Co Tyrone, as part of a £9.6m investment at its fertiliser plant in Dungannon.
Pascalle is to create 20 new jobs at its Staffordshire-based cosmetics business, having won a £5m contract to supply Poundworld.
Alfa Aesar, the Lancashire-based laboratory chemicals manufacturer with 480 staff, has been acquired by Thermo Fisher Scientific for £256m.
The Little Greene Paint Company has submitted plans for a new 29,000 sq ft warehouse and office in East Manchester.
Empress Garland has acquired Ramon Hygiene Products, the Leicester-based supplier of cleaning products with annual turnover of £15m.
Quotient Clinical is planning to expand the 249-strong workforce at its Nottingham-based pharmaceuticals development business by 50% over the next three years.
Huntsman, the chemical manufacturer, has announced the creation of 70 jobs at its new customer care centre at Wynyard, near Stockton.
Neem Biotech is to create 17 new jobs at its recently-opened £2m 15,000 sq ft biotechnology facility in Abertillery over the next 18 months.
Monsanto is considering proposals to transfer the headquarters of its agrochemicals business from the US to the UK.
Oxford University has submitted plans for a new BioEscalator biotech research hub at the Old Road campus, including laboratory and office space.
Intertek is to create a further ten jobs at its new 8,000 sq ft pharmaceuticals storage facility at Royston in Hertfordshire over the next year.
Redx Pharma is to create 30 jobs at its new Redx Immunology subsidiary at Alderley Park in Cheshire over the next year.
Spencer Coatings has acquired Protega Paints, the West Bromwich-based coatings manufacturer with 56 staff.
Joseph Clayton & Sons has acquired J&E Sedgwick & Co, the Walsall-based leather tannery, for undisclosed terms.
Clinigen is to acquire Idis, the Surrey-based supplier of unlicensed prescription drugs with 189 staff, for £225m.
James Briggs has acquired Premiere Products, the Cheltenham-based cleaning chemicals manufacturer.
PRA Health Sciences is to expand its clinical research facility in Swansea, with the creation of 87 graduate jobs by 2017.
Quantum Pharma of Durham has acquired Lamda, the Greek-owned pharmaceuticals research and development firm, for £6.9m.
BioOutsource, the Glasgow-based pharmaceutical testing firm with 85 staff, has been acquired by Sartorius Stedim Biotech for undisclosed terms.
Almac is to relocate its peptide manufacturing business and 15 staff from Elvingston to a new £3.5m 7,000 sq ft laboratory at Technopole in Edinburgh.
Graham Construction has won a £17m contract to refurbish the University College London Courtauld Building research laboratory.
Coventry Chemicals is to expand the 140-strong workforce at its cleaning products business with ten new jobs, having secured a £1.7m cash injection.
GlaxoSmithKline Research & Development is to relocate its Manchester office to a 10,000 sq ft unit at Exchange Quay.
Neem Biotech is to relocate its Newport-based research business to a larger £2m facility in Abertillery, with the creation of 18 jobs.
ICL Fertilizers is to build a fertilizer granulation plant at its Cleveland Potash mine in Boulby, as part of a £50m expansion programme.
Cleveland Biotech is planning to merge with Caerphilly-based Biological Preparations, as part of a £3.5m investment by NVM Private Equity.
Wax Lyrical is to invest £1m in the expansion of its home fragrances factory and laboratory in Cumbria.
Willmott Dixon is to build a 50,000 sq ft life sciences incubator at BioCity in Nottingham, with the creation of 300 jobs.
BioKinetic Europe is to create 19 new jobs at its Belfast-based clinical trials business.
Bayer is looking to relocate its UK pharmaceuticals headquarters to a new site of about 80,000 sq ft between Newbury and Reading.
Synexus, the Manchester-based clinical trials company with 600 staff, has undergone a £83m management buy-out backed by LDC.
Elucigene Diagnostics, the supplier of DNA testing kits, has acquired an 8,000 sq ft office for 20 staff at Citylabs in Manchester.
Alcohols is planning to build a 43,000 sq ft gin distillery and chemicals plant near Rugby, in order to transfer production from Langley Green, Bishop's Stortford and London.
Smithers Viscient is to set up a 29,000 sq ft environmental research laboratory at Brixham in Devon, with the creation of an unspecified number of jobs.
SGS has won a contract to operate an assay laboratory at the new £130m Wolf Minerals tungsten mine near Plymouth, with the creation of 13 jobs.
Avacta Group of Wetherby has sold its Optim protein analysis division to US-based Unchained Labs for up to £3.3m.
Gilead Sciences of the US is to expand its biotechnology operations in London, Uxbridge and Cambridge this year, doubling the workforce to 600.
Deb Group, the Derbyshire-based skin care products manufacturer with turnover of £122m, is to be acquired by US-based SC Johnson for undisclosed terms.
AstraZeneca has won permission from Cambridge City Council to build a new £330m headquarters for 2,000 staff by the end of 2016.
University of Cumbria is to invest £1.2m in new laboratory facilities at its campus in Carlisle this year.
Hart Biologicals is expanding its Hartlepool-based medical reagents business into an adjacent 6,500 sq ft unit, with the creation of 13 jobs.
Alliance Pharma has acquired MacuVision Europe, the Solihull-based supplier of eye care treatments, for an initial £5.5m.
The University of Edinburgh has won government funding of £11m for a new Centre for Mammalian Synthetic Biology, while Manchester and Warwick will both get £10m.
Actavis has acquired Auden Mckenzie, the Middlesex-based pharmaceuticals supplier, for £306m.
Rokshaw is to set up a 6,000 sq ft laboratory and factory for its Sunderland-based pharmaceuticals business, with the creation of an initial nine jobs.
Barry M Cosmetics is planning to set up a 30,000 sq ft cosmetics factory at Mill Hill in London, with the creation of 100 jobs.
Crawford Scientific has acquired Hall Analytical Laboratories, the Manchester-based contract research firm.
SCIO Health Analytics of the US has acquired Data Intelligence, the Slough-based provider of life sciences business intelligence.
Sygnature Discovery is to set up a 33,000 sq ft pharmaceuticals research centre at a new biosciences hub due to open in Nottingham in 2016, with the creation of 80 jobs.
PathXL is to invest £3.6m in the expansion of its Belfast-based digital pathology business, with the creation of 32 jobs over the next three years.
Crown Bioscience is planning to double the size of its Precos oncology research centre in Nottingham, and will rename the business as Crown UK.
Aptuit, the Glasgow-based pharmaceuticals manufacturer, has been acquired by US-based Albany Molecular Research for £16m.
Edelchemie UK is seeking permission to expand production at its fertiliser plant in Northwich and increase the workforce from 18 to 70.
Vitax has acquired Organico, the Somerset-based fertiliser manufacturer, for undisclosed terms.
Benchmark Vaccines has submitted plans to build a three-storey biotechnology laboratory in Braintree.
Warwick Chemicals, the Flintshire-based manufacturer of cleaning additives with 160 staff, is to be acquired by US-based Lubrizol.